TCGX — TCGX Acquisition Corp.

—
Nasdaq · Financials · Diversified Financial Services · CIK 2137965 · Cayman Islands
Last close
$10.03
Market Cap
$80.24M
52W High
$18.91
52W Low
$9.90
ADV30
171,917
Next earnings
—
TCGX Acquisition Corp. focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was incorporated in 2026 and is based in Palo Alto, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 0 — -459,135 24,176 89,718,487 2,672,345 4,098,979
Jun 2026 — — — — 253,176 — 295,790
May 2026 — — — — 218,437 — 225,076

Balance + Analyst (yfinance extras)

Retained Earnings
$-1,114,071
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-459,135
Pretax Income TTM
$24,176
Interest Exp TTM
—
Analysts
—

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
$253,176
Forward EPS
—

Peers — same industry

TickerNameMarket CapLastDaily %
RACD Research Alliance Corp IV $80.47M $10.35 —
SSEA STARRY SEA ACQUISITION CORP $79.79M $10.45 —
JATT JATT II Acquisition Corp. $79.56M $10.20 —
RENEF Cartesian Growth Corp II $79.12M $12.71 —
AMAN Amanat Acquisition Corp. $78.70M $10.09 —

News headlines (Yahoo Finance, 1h cache)

TriGemX Bio Appoints Daniel Lynch as Chairman of the TriGemX Bio Board of Directors
2026-11-09 12:00 · Yahoo
TriGemX Bio and TCGX Acquisition Corp. Announce Confidential Submission of Draft Registration Statement on Form S-4 in Connection with Proposed Business Combination
2026-11-02 11:00 · Yahoo
TriGemX Bio and TCGX Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Company to Develop Elismetrep, a Potential First-in-Class Treatment for Migraine
2026-10-19 11:00 · Yahoo
TriGemX Bio and TCGX Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Company to Develop Elismetrep, A Potential First-in-Class Treatment for Migraine
2026-10-19 11:00 · Yahoo
TCGX Acquisition Corp. II Announces Pricing of $100,000,000 Initial Public Offering
2026-10-15 21:13 · Yahoo
TCGX Acquisition Corp. Announces Completion of its Initial Public Offering
2026-08-06 20:05 · Yahoo
TCGX Acquisition Corp. Announces Pricing of $75,000,000 Initial Public Offering
2026-08-04 23:10 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.